Beta Bionics, Inc. (BBNX) Cash & Current Investments (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Cash & Current Investments data on file, last reported at $30.3 million in Q1 2026.

• Quarterly Cash & Current Investments fell 86.91% year-over-year to $30.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.3 million (down 86.91% YoY) and the FY2025 annual result came in at $219.1 million, up 111.56% from the prior year.
• Cash & Current Investments eased to $30.3 million in Q1 2026 per BBNX's latest filing, from $219.1 million in the prior quarter.
• The five-year high for Cash & Current Investments was $249.7 million in Q2 2025, with the low at $13.0 million in Q2 2024.
• Average Cash & Current Investments over 4 years is $121.2 million, with a median of $100.2 million recorded in 2023.
• Year-over-year, Cash & Current Investments jumped 1816.65% in 2025 and plunged 86.91% in 2026.
• Beta Bionics' Cash & Current Investments stood at $96.7 million in 2023, then grew by 7.06% to $103.6 million in 2024, then surged by 111.56% to $219.1 million in 2025, then plunged by 86.17% to $30.3 million in 2026.
• Business Quant data shows BBNX's Cash & Current Investments at $30.3 million in Q1 2026, $219.1 million in Q4 2025, and $228.7 million in Q3 2025.